THURSDAY, Sept. 16, 2021 (HealthDay News) — Millions of people take statins to lower their cholesterol, and new research suggests these drugs may also ease ulcerative colitis. An inflammatory bowel disease with no real cure, ulcerative colitis causes sore spots on the lining of the colon that can lead toContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — Even when genetics and personality are working against you, having a strong network of supportive friends and family may help lower alcoholism risk, researchers say. “Genes play an important role in alcohol use,” stressed Jinni Su, an assistant professor of psychology at ArizonaContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — America’s waistline keeps widening. On Wednesday, the U.S. Centers for Disease Control and Prevention announced that 16 states now have at least 35% of their residents who are obese, a number that’s nearly doubled since 2018. The CDC’s 2020 Adult Obesity Prevalence MapsContinue Reading
Here are some of HealthDay’s top stories for Thursday, Sept. 16: NIH spending nearly $470 million on long-haul COVID study. “Some people have had their lives completely upended by the major long-term effects of COVID-19,” said Dr. Francis Collins, director of the National Institutes of Health. A major research initiativeContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — The cost of providing hospital care for unvaccinated Americans has reached $5.7 billion in just three months, CBS News reported. Between June and August, about 287,000 people who were not vaccinated were hospitalized for COVID-19 in the United States, according to data fromContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — The U.S. National Institutes of Health is spending nearly $470 million to study the long-term effects of COVID-19, the agency announced Wednesday. NIH has awarded a “parent” grant to New York University (NYU) Langone Health, which will in turn make awards to moreContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers. Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection. The BidenContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients undergoing a treatment that depletes a type of immune cell that fuels MS attacks still have a strong response to mRNA COVID-19 vaccines, a new study finds. “The message from this study is clear — it is worthwhile forContinue Reading
THURSDAY, Sept. 16, 2021 (HealthDay News) — Multiple sclerosis (MS) patients diagnosed with colon cancer may have a greater risk of dying from cancer or other causes in the next six months to year than colon cancer patients without MS, a Canadian study finds. “These results warrant further investigation toContinue Reading
WEDNESDAY, Sept. 15, 2021 (HealthDay News) — One out of every 500 U.S. residents has lost their lives to COVID-19 since the start of the pandemic last year, statistics show. COVID has killed more than 664,500 people in the United States as of Wednesday, according to tracking data from JohnsContinue Reading